These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Differences in diagnostic activity in general practice and findings for individuals invited to the danish screening programme for colorectal cancer: a population-based cohort study. Juul JS; Andersen B; Laurberg S; Carlsen AH; Olesen F; Vedsted P Scand J Prim Health Care; 2018 Sep; 36(3):281-290. PubMed ID: 29929415 [TBL] [Abstract][Full Text] [Related]
24. Setting up a service for a faecal immunochemical test for haemoglobin (FIT): a review of considerations, challenges and constraints. Godber IM; Benton SC; Fraser CG J Clin Pathol; 2018 Dec; 71(12):1041-1045. PubMed ID: 30275098 [TBL] [Abstract][Full Text] [Related]
25. Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design. Juul JS; Bro F; Hornung N; Andersen BS; Laurberg S; Olesen F; Vedsted P BMC Cancer; 2016 Jul; 16():445. PubMed ID: 27400657 [TBL] [Abstract][Full Text] [Related]
26. Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test. Birkenfeld S; Belfer RG; Chared M; Vilkin A; Barchana M; Lifshitz I; Fruchter D; Aronski D; Balicer R; Niv Y; Levi Z J Med Screen; 2011; 18(3):135-41. PubMed ID: 22045822 [TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England. Murphy J; Halloran S; Gray A BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605 [TBL] [Abstract][Full Text] [Related]
28. Awareness of investigations and treatment of faecal incontinence among the general practitioners: a postal questionnaire survey. Thekkinkattil DK; Lim M; Finan PJ; Sagar PM; Burke D Colorectal Dis; 2008 Mar; 10(3):263-7. PubMed ID: 17608749 [TBL] [Abstract][Full Text] [Related]
29. General practitioners' views of clinically led commissioning: cross-sectional survey in England. Moran V; Checkland K; Coleman A; Spooner S; Gibson J; Sutton M BMJ Open; 2017 Jun; 7(6):e015464. PubMed ID: 28596217 [TBL] [Abstract][Full Text] [Related]
30. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake. Todorov K; Wilson C; Sharplin G; Corsini N Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632 [TBL] [Abstract][Full Text] [Related]
31. Feasibility of immunochemical faecal occult blood testing for colorectal cancer screening in Bulgaria. Tsvetanova Dimova R; Dimitrova Dimitrova D; Angelova Levterova B; Stoyanov Dimov R; Atanasova Semerdjieva M; Frantova Tarnovska M; Gencheva Stoyanova R J BUON; 2015; 20(2):413-20. PubMed ID: 26011330 [TBL] [Abstract][Full Text] [Related]
32. Colorectal cancer screening in general practice. A survey of current practice and attitudes in Victoria. Martyres R; St John DJ; Irving FH; Wyman K Aust Fam Physician; 1999 Jul; 28(7):755-8. PubMed ID: 10431443 [TBL] [Abstract][Full Text] [Related]
33. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer. Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194 [TBL] [Abstract][Full Text] [Related]
34. An online questionnaire survey of UK general practitioners' knowledge and management of familial hypercholesterolaemia. Kwok S; Pang J; Adam S; Watts GF; Soran H BMJ Open; 2016 Nov; 6(11):e012691. PubMed ID: 28186938 [TBL] [Abstract][Full Text] [Related]
35. An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test. Rodríguez-Alonso L; Rodríguez-Moranta F; Ruiz-Cerulla A; Lobatón T; Arajol C; Binefa G; Moreno V; Guardiola J Dig Liver Dis; 2015 Sep; 47(9):797-804. PubMed ID: 26055489 [TBL] [Abstract][Full Text] [Related]
36. General practitioners' perceptions of population based bowel screening and their influence on practice: a qualitative study. Dawson G; Crane M; Lyons C; Burnham A; Bowman T; Perez D; Travaglia J BMC Fam Pract; 2017 Mar; 18(1):36. PubMed ID: 28298185 [TBL] [Abstract][Full Text] [Related]
37. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Smith A; Young GP; Cole SR; Bampton P Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938 [TBL] [Abstract][Full Text] [Related]
38. Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community. Hughes K; Leggett B; Del Mar C; Croese J; Fairley S; Masson J; Aitken J; Clavarino A; Janda M; Stanton WR; Tong S; Newman B Aust N Z J Public Health; 2005 Aug; 29(4):358-64. PubMed ID: 16222934 [TBL] [Abstract][Full Text] [Related]
39. Inappropriate use of the faecal occult blood test outside of the National Health Service colorectal cancer screening programme. Peacock O; Watts ES; Hanna N; Kerr K; Goddard AF; Lund JN Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1270-5. PubMed ID: 22872076 [TBL] [Abstract][Full Text] [Related]